BlackRock’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
422,758
+106,228
| +34% | +$358K | ﹤0.01% | 4078 |
|
|
2025
Q1 | $481K | Sell |
316,530
-2,233
| -0.7% | -$3.39K | ﹤0.01% | 4365 |
|
|
2024
Q4 | $701K | Buy |
318,763
+344
| +0.1% | +$757 | ﹤0.01% | 4267 |
|
|
2024
Q3 | $793K | Sell |
318,419
-214,945
| -40% | -$535K | ﹤0.01% | 4178 |
|
|
2024
Q2 | $683K | Sell |
533,364
-843,756
| -61% | -$1.08M | ﹤0.01% | 4221 |
|
|
2024
Q1 | $3.98M | Sell |
1,377,120
-720,286
| -34% | -$2.08M | ﹤0.01% | 3712 |
|
|
2023
Q4 | $15.4M | Sell |
2,097,406
-414,612
| -17% | -$3.05M | ﹤0.01% | 3091 |
|
|
2023
Q3 | $19.3M | Buy |
2,512,018
+88,360
| +4% | +$679K | ﹤0.01% | 2912 |
|
|
2023
Q2 | $24.6M | Buy |
2,423,658
+1,083,465
| +81% | +$11M | ﹤0.01% | 2843 |
|
|
2023
Q1 | $13M | Sell |
1,340,193
-8,191
| -0.6% | -$79.5K | ﹤0.01% | 3116 |
|
|
2022
Q4 | $6.54M | Sell |
1,348,384
-75,650
| -5% | -$367K | ﹤0.01% | 3528 |
|
|
2022
Q3 | $20.4M | Buy |
1,424,034
+67,364
| +5% | +$965K | ﹤0.01% | 2973 |
|
|
2022
Q2 | $7.34M | Sell |
1,356,670
-766,704
| -36% | -$4.15M | ﹤0.01% | 3579 |
|
|
2022
Q1 | $13.7M | Buy |
2,123,374
+407,204
| +24% | +$2.63M | ﹤0.01% | 3327 |
|
|
2021
Q4 | $27.8M | Buy |
1,716,170
+191,796
| +13% | +$3.1M | ﹤0.01% | 3010 |
|
|
2021
Q3 | $40.5M | Buy |
+1,524,374
| New | +$40.5M | ﹤0.01% | 2767 |
|